Holdings (as at 2026-04-30)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 3.82%
Humana Inc. 2.94%
Elevance Health Inc. 2.77%
Molina Healthcare, Inc. 2.52%
The Cigna Group 2.35%
Globus Medical, Inc. (Class A) 2.26%
Exelixis, Inc. 2.24%
Biogen Inc. 2.23%
Solventum Corporation 2.22%
Incyte Corporation 2.18%
DaVita Inc. 2.18%
Bio-Rad Laboratories, Inc. (Class A) 2.17%
Universal Health Services, Inc. (Class B) 2.03%
Regeneron Pharmaceuticals, Inc. 1.98%
HCA Healthcare, Inc. 1.98%
Cardinal Health, Inc. 1.97%
Zimmer Biomet Holdings, Inc. 1.97%
Chemed Corporation 1.94%
Encompass Health Corporation 1.78%
Masimo Corporation 1.73%
Ionis Pharmaceuticals, Inc. 1.72%
Penumbra, Inc. 1.71%
Amgen Inc. 1.70%
United Therapeutics Corporation 1.67%
Pfizer Inc. 1.64%
Becton, Dickinson and Company 1.64%
Tenet Healthcare Corporation 1.62%
Merck & Co., Inc. 1.57%
QIAGEN N.V. 1.49%
Insmed Incorporated 1.44%
Certara, Inc. 1.39%
Illumina, Inc. 1.33%
Natera, Inc. 1.33%
Henry Schein, Inc. 1.31%
Bristol-Myers Squibb Company 1.29%
Quest Diagnostics Incorporated 1.28%
Revvity, Inc. 1.28%
Steris Plc 1.27%
Labcorp Holdings Inc. 1.25%
Sarepta Therapeutics, Inc. 1.24%
ResMed Inc. 1.23%
Medtronic Plc 1.21%
Gilead Sciences, Inc. 1.21%
UnitedHealth Group Incorporated 1.18%
The Cooper Companies, Inc. 1.14%
GE HealthCare Technologies Inc. 1.11%
Waters Corporation 0.90%
Align Technology, Inc. 0.89%
Eli Lilly and Company 0.88%
Agilent Technologies, Inc. 0.88%
Neurocrine Biosciences, Inc. 0.86%
Medline Inc. (Class A) 0.86%
Halozyme Therapeutics, Inc. 0.85%
Thermo Fisher Scientific Inc. 0.84%
Zoetis Inc. 0.84%
BioMarin Pharmaceutical Inc. 0.82%
Johnson & Johnson 0.81%
IQVIA Holdings Inc. 0.80%
Abbott Laboratories 0.76%
Medpace Holdings, Inc. 0.75%
West Pharmaceutical Services, Inc. 0.48%
Sotera Health Company 0.44%
Edwards Lifesciences Corporation 0.42%
Royalty Pharma Plc (Class A) 0.42%
Envista Holdings Corporation 0.41%
IDEXX Laboratories, Inc. 0.40%
Intuitive Surgical, Inc. 0.40%
Stryker Corporation 0.39%
Vertex Pharmaceuticals Incorporated 0.39%
AbbVie Inc. 0.39%
Viking Therapeutics, Inc. 0.39%
Danaher Corporation 0.38%
Alnylam Pharmaceuticals, Inc. 0.38%
DexCom, Inc. 0.38%
Boston Scientific Corporation 0.37%
Veeva Systems Inc. (Class A) 0.36%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.